Skip to content
Tenfell
Awarded contract
Published 23 Aug 2024

NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024

NHS England · London

Key facts

Awarded
24 Jul 2024
Contract starts
31 Jul 2024
Contract ends
31 Jul 2025
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 9 suppliers

SupplierValue
Teva UK Ltd—
Bayer plc—
Abbvie Ltd—
Thornton & Ross Ltd—
Biogen—
Novartis Pharmaceuticals UK Ltd—
Roche Products Ltd—
Orion Pharma (UK) Ltd—
Alimera Sciences—

Description

roject title: CM/PHS/24/5707 NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024 Period of framework: 1 August 2024 to 31 July 2025. with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder (Open Government Licence v3.0). Always read the original notice before responding.